TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

Anna C. Groner(Harvard University), Laura Cato(Harvard University), Jonas de Tribolet-Hardy(Harvard University), Tiziano Bernasocchi(Institute of Oncology Research), Hana Janoušková(Institute of Oncology Research), Diana Melchers(PamGene (Netherlands)), René Houtman(PamGene (Netherlands)), Andrew C.B. Cato(Karlsruhe Institute of Technology), Patrick Tschopp(Harvard University), Lei Gu(Boston Children's Hospital), Andrea Corsinotti(University of Tsukuba), Qing Zhong(University Hospital of Zurich), Christian D. Fankhauser(University Hospital of Zurich), Christine Fritz(University Hospital of Zurich), Cédric Poyet(University Hospital of Zurich), Ulrich Wagner(University Hospital of Zurich), Tiannan Guo(ETH Zurich), Ruedi Aebersold(University of Zurich), Levi A. Garraway(Broad Institute), Peter J. Wild(University Hospital of Zurich), Jean‐Philippe Theurillat(Broad Institute), Myles Brown(Harvard University)
Cancer Cell
May 28, 2016
10.1016/j.ccell.2016.04.012
Cited by 286Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis